Phase II study of CC-5013 [lenalidomide] in patients with advanced renal cell carcinoma (RCC)
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2017
At a glance
- Drugs Lenalidomide (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 18 Apr 2017 Status changed from active, no longer recruiting to completed.
- 12 Feb 2009 Additional lead investigator identified as reported by ClinicalTrials.gov, last updated 12-2-2009.
- 01 Mar 2007 New trial record.